Article
Cellular mechanisms of acquired drug resistance against regorafenib in colon cancer cells
2026-02-05
Abstract excerpt
Colorectal cancer is the third most common cancer across the world. Acquired resistance to therapeutics is one of the major challenges in cancer cure. With the development of resistance to organometallic drugs there was switch for the usage of inhibitors of kinases which play a crucial role in cellular activities. Regorafenib is a multi-kinase inhibitor used as an oral anti-cancer drug for treating advanced colore...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6a749106-ee01-580c-8acb-2bd3f0179260
- DOI
- 10.64898/2026.02.03.703469